YO-HEALTH, INC.

EDGAR

7 filing records in this dataset, filed from 2023-04-17 to 2024-03-18. Reported financial figures are available; chart coverage varies by period.

Watchlist

Latest quarter

Revenue

2.5 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating margin

-37.06%

2023 Q3 · %

Exact inputs and evidence
  • Operating Income: -926564 USD Source
  • Revenue: 2500311 USD Source

Operating cash flow

-254 thousand USD

2023 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -882670 USD Source
  • Operating Cash Flow: -628977 USD Source

Free cash flow

-254 thousand USD

2023 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -882670 USD Source
  • Operating Cash Flow: -628977 USD Source
  • Capital Expenditure: 49289 USD Source
  • Capital Expenditure: 49289 USD Source
Cash and cash equivalents
Not available
Long-term debt including current maturities
Not available
Shares outstanding
77.2 million shares Source
Exact value

77226355 shares

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-03-18.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2022-12-31
  • Operating income: 2 of 11 periods available· newest 2022-12-31
  • Net income: 2 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2022-12-31
  • Total assets: 2 of 11 periods available· newest 2022-12-31
  • Total liabilities: 2 of 11 periods available· newest 2022-12-31
  • Current assets: 2 of 11 periods available· newest 2022-12-31
  • Current liabilities: 2 of 11 periods available· newest 2022-12-31
  • cash and cash equivalents: No compatible figures in this window
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +162.8%

    Prior period

    USD 1.56 million

    –

    Current period

    USD 4.09 million

    –

    Exact inputs and evidence

    4093212 − 1557375 = 2535837 USD

    1557375 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    4093212 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 7.74 million

    Prior period

    −USD 3.14 million

    –

    Current period

    −USD 10.88 million

    –

    Exact inputs and evidence

    -10881122 − -3143480 = -7737642 USD

    -3143480 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -10881122 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 370,949

    Prior period

    −USD 1.2 million

    –

    Current period

    −USD 833,452

    –

    Exact inputs and evidence

    -833452 − -1204401 = 370949 USD

    -1204401 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -833452 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +6.7%

    Prior period

    USD 1.94 million

    –

    Current period

    USD 2.07 million

    –

    Exact inputs and evidence

    2068562 − 1939340 = 129222 USD

    1939340 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    2068562 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

  • Revenue USD 4.09 million 100% of revenue
  • Cost of revenue USD 3.07 million 75% of revenue
  • Operating expenses USD 11.85 million 290% of revenue
  • Operating income −USD 10.83 million −265% of revenue
  • Tax, interest and other Derived USD 51,405 1.3% of revenue
  • Net income −USD 10.88 million −266% of revenue

Cash

  • Operating cash flow −USD 833,452 −20% of revenue
  • Capital expenditure USD 2.07 million 51% of revenue
  • Free cash flow Derived −USD 2.9 million −71% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Operating loss: operating costs were 301% of revenue.
  • 2022 Operating loss: operating costs were 365% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-311557375 4684954 Derived -3127579 15901 Derived -3143480 -3143741 Derived
Source
2022 2022-01-01 – 2022-12-314093212 14922929 Derived -10829717 51405 Derived -10881122 -2902014 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.1M 2022
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.4M3.3M2.2M1.1M0.020212022
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue1557375
2022Revenue4093212

Revenue growth

Change in revenue from the same financial period one year earlier.

162.8% 2022
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.176%132%88%44%0%20212022
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over year162.8%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -264.6% 2022
Net margin -265.8% 2022
Free cash flow margin -70.9% 2022
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.21%-56%-133%-210%-287%20212022
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating margin-200.8%
2022Operating margin-264.6%
2021Net margin-201.8%
2022Net margin-265.8%
2021Free cash flow margin-201.9%
2022Free cash flow margin-70.9%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -833.5K 2022
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.96.4K-252.9K-602.2K-951.5K-1.3M20212022
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-1204401
2022Operating cash flow-833452

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.9M 2022
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.251.5K-660.2K-1.6M-2.5M-3.4M20212022
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flow-3143741
2022Free cash flow-2902014

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

51.3% 2022
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.55%42%28%14%0%20212022
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets26.4%
2022Liabilities / assets51.3%

Current assets to current liabilities

Current assets divided by current liabilities.

0.98× 2022
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.85×9.64×6.43×3.21×0.00×20212022
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities11.9×
2022Current assets / current liabilities0.98×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−USD 3.14 million
Exact value

Exact value: -3143480 USD

2021-01-01 – 2021-12-31: -3143480 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.2 million
Exact value

Exact value: -1204401 USD

2021-01-01 – 2021-12-31: -1204401 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.94 million
Exact value

Exact value: 1939340 USD

2021-01-01 – 2021-12-31: 1939340 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.14 million
Calculation and evidence

-1204401 − 1939340 USD

Exact free cash flow: -3143741 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 10.88 million
Exact value

Exact value: -10881122 USD

2022-01-01 – 2022-12-31: -10881122 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 833,452
Exact value

Exact value: -833452 USD

2022-01-01 – 2022-12-31: -833452 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.07 million
Exact value

Exact value: 2068562 USD

2022-01-01 – 2022-12-31: 2068562 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.9 million
Calculation and evidence

-833452 − 2068562 USD

Exact free cash flow: -2902014 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

7 filings · 409 latest values · 409 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001844793, 1844793, edgar:1844793

Also known as YO-HEALTH, INC, YO-HEALTH, INC., Yo-Health Inc.